Articles citing this paper
General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting
Stephen M. Lambert A H , Andrew N. Page B , Johannes Wittmann C , Jeremy S. Hayllar D , Clint W. Ferndale E , Tanya M. Bain F and Graeme A. Macdonald G
+ Author Affiliations
- Author Affiliations
A School of Medicine, The University of Queensland, 288 Herston Road, Herston, Qld 4051, Australia.
B Discipline of Epidemiology and Biostatistics, School of Population Health, The University of Queensland, 288 Herston Road, Herston, Qld 4051, Australia.
C Department of Gastroenterology, Mater Adult Hospital, Raymond Terrace, South Brisbane, Qld 4101, Australia.
D Alcohol and Drug Service, Metro North Health Service District, Queensland Health, PO Box 8161, Brisbane, Qld 4000, Australia.
E Hepatitis Council of Queensland, 30 Herschel Street Brisbane, Qld 4000, Australia.
F Communicable Diseases Branch, Queensland Health, Level 1, 15 Butterfield Street, Herston, Qld 4006, Australia.
G Department of Gastroenterology and Hepatology and School of Medicine, The University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia.
H Corresponding author. Email: s.lambert@uq.edu.au
Australian Journal of Primary Health 17(3) 282-287 https://doi.org/10.1071/PY10069
Submitted: 4 October 2010 Accepted: 21 February 2011 Published: 5 September 2011
16 articles found in Crossref database.
Outcomes of a tertiary-based innovative approach to engage primary care providers in provision of hepatitis C treatment in community settings
Pourmarzi Davoud,
Thompson Hayley,
Thomas James A.,
Hall Lisa,
Smirnov Andrew,
FitzGerald Gerard, Rahman Tony
BMC Public Health. 2019 19(1).
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study
Litwin Alain H.,
Drolet Martine,
Nwankwo Chizoba,
Torrens Martha,
Kastelic Andrej,
Walcher Stephan,
Somaini Lorenzo,
Mulvihill Emily,
Ertl Jochen, Grebely Jason
Journal of Viral Hepatitis. 2019 26(9). p.1094
Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model
Cachay Edward R,
Hill Lucas,
Ballard Craig,
Colwell Bradford,
Torriani Francesca,
Wyles David, Mathews William C
AIDS Research and Therapy. 2013 10(1). p.9
A Qualitative Study of Implementing Universal Hepatitis C Screening Among Adults at an Urban Community-Based Health Provider in Delaware
Jose Rini,
Kahal Deborah,
Testa Karla, Goldstein Neal D.
Delaware Journal of Public Health. 2021 7(3). p.16
Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
Grebely Jason,
Oser Megan,
Taylor Lynn E., Dore Gregory J.
The Journal of Infectious Diseases. 2013 207(suppl_1). p.S19
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
Grebely Jason,
Hajarizadeh Behzad, Dore Gregory J.
Nature Reviews Gastroenterology & Hepatology. 2017 14(11). p.641
Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review
Hepworth Julie,
Bain Tanya, van Driel Mieke
International Journal for Equity in Health. 2013 12(1). p.92
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study
Grebely Jason,
Drolet Martine,
Nwankwo Chizoba,
Torrens Martha,
Kastelic Andrej,
Walcher Stephan,
Somaini Lorenzo,
Mulvihill Emily,
Ertl Jochen,
Liebert Ryan, Litwin Alain H.
International Journal of Drug Policy. 2019 63 p.29
Framework for community-based models for treating hepatitis C virus
Pourmarzi Davoud,
Hall Lisa,
Smirnov Andrew,
Hepworth Julie,
Rahman Tony, FitzGerald Gerard
Australian Health Review. 2020 44(3). p.459
Elements of community‐based models for treating hepatitis C virus in supporting HCV elimination in Australia: A Delphi study
Pourmarzi Davoud,
Smirnov Andrew,
Hepworth Julie,
Rahman Tony,
FitzGerald Gerrard, Hall Lisa
The International Journal of Health Planning and Management. 2019 34(2).
A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia
Lee Andrew,
Hanson Josh,
Fox Penny,
Spice Greg,
Russell Darren, Boyd Peter
Journal of Virus Eradication. 2018 4(3). p.160
The Elimination of Hepatitis C as a Public Health Threat
Hellard Margaret,
Schroeder Sophia E.,
Pedrana Alisa,
Doyle Joseph, Aitken Campbell
Cold Spring Harbor Perspectives in Medicine. 2020 10(4). p.a036939
Identifying barriers to treatment of HCV in the primary care setting
Johnson Steve,
Aluzaite Kristina,
Taar Anna, Schultz Michael
Hepatology International. 2019 13(1). p.58
‘Sussing that doctor out.’ Experiences and perspectives of people affected by hepatitis C regarding engagement with private general practitioners in South Australia: a qualitative study
Scarborough Jane,
Miller Emma Ruth,
Aylward Paul, Eliott Jaklin
BMC Family Practice. 2017 18(1).
A survey of Australian general practitioners’ hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available
Gooey Michelle,
Wong Evelyn,
Pedrana Alisa,
Allard Nicole,
Doyle Joseph,
Hellard Margaret, Wade Amanda
Sexual Health. 2020 17(4). p.387
Enablers and barriers for the provision of community‐based HCV treatment: A case study of a real‐world practice
Pourmarzi Davoud,
Smirnov Andrew,
Hall Lisa,
Thompson Hayley,
FitzGerald Gerard, Rahman Tony
Journal of Viral Hepatitis. 2020 27(5). p.484
